J Periodont Res 2016; 51: 143–151 All rights reserved

Class I and II histone deacetylase expression in human chronic periodontitis gingival tissue

Histone deacetylase inhibitors (HDACi) are being considered to treat chronic inflammatory diseases at low doses. Currently HDACi that are more specific are being developed to target particular HDACs; therefore, this study aimed to determine levels and distribution of class I and II HDAC in human gingival samples obtained from patients with chronic periodontitis.


Disfrutas de leer nuestro Blog? Compartelo